R&D, Pharmacovigilance & Regulatory Affairs_uk

R&D, Pharmacovilance & Regulatory Affairs

Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.

  • R&D, Pharmacovilance & Regulatory Affairs

    Researching, developing, testing and launching new drug solutions. The development process lasts from 8 to 10 years and is made up of 4 phases.
Title Location Date Sort descending Req ID
Reset
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases Europe, IT 17 Mar 2026 6111
Europe, IT 17 Mar 2026 6111
Senior Director, Clinical Biometrics & Analytics
Senior Director, Clinical Biometrics & Analytics Parma, IT 13 Mar 2026 6387
Parma, IT 13 Mar 2026 6387
Master's thesis in computational modelling of aerosol deposition in respiratory system
Master's thesis in computational modelling of aerosol deposition in respiratory system Parma, IT 13 Mar 2026 6598
Parma, IT 13 Mar 2026 6598
Clinical Program Leader
Clinical Program Leader Cary, NC, US 13 Mar 2026 7017
Cary, NC, US 13 Mar 2026 7017
Senior Manager, CMC Regulatory Affairs, Global Rare Diseases
Senior Manager, CMC Regulatory Affairs, Global Rare Diseases Europe, IT 11 Mar 2026 6592
Europe, IT 11 Mar 2026 6592
Pharmazeut (all genders) im Praktikum für 2026 / 2027
Pharmazeut (all genders) im Praktikum für 2026 / 2027 Hamburg, DE 7 Mar 2026 351
Hamburg, DE 7 Mar 2026 351
INTERN - Patient Engagement
INTERN - Patient Engagement PARMA, IT 27 Feb 2026 5993
PARMA, IT 27 Feb 2026 5993
Sr. Manager, CMC Regulatory Affairs
Sr. Manager, CMC Regulatory Affairs United States, US 20 Feb 2026 6204
United States, US 20 Feb 2026 6204
Clinical Program Leader, Neonatology & Care
Clinical Program Leader, Neonatology & Care Europe, IT 19 Feb 2026 6955
Europe, IT 19 Feb 2026 6955